BATS | ETF
Under normal market conditions, the fund invests at least 80% of its net assets in equity securities of companies that are relevant to its investment theme of genomic advancements.
The fund invests predominantly in common stock.
Although it may invest across economic sectors, the fund concentrates its investments in health care related industries.
It is non-diversified.
Top 20 Holdings
| Asset | Name | Sector | Industry | Weight |
|---|---|---|---|---|
| NTRA | Natera Inc | Healthcare | Diagnostics & Research | 6.76% |
| GH | Guardant Health Inc | Healthcare | Diagnostics & Research | 6.52% |
| KRYS | Krystal Biotech Inc | Healthcare | Biotechnology | 5.35% |
| INSM | Insmed Inc | Healthcare | Biotechnology | 4.50% |
| UTHR | United Therapeutics Corporation | Healthcare | Drug Manufacturers - Specialty & Generic | 4.35% |
| BBIO | BridgeBio Pharma Inc | Healthcare | Biotechnology | 4.08% |
| LGND | Ligand Pharmaceuticals Incorporated | Healthcare | Biotechnology | 3.58% |
| AZN | AstraZeneca PLC | Healthcare | Drug Manufacturers - General | 3.47% |
| ADPT | Adaptive Biotechnologies Corp | Healthcare | Biotechnology | 3.14% |
| 207940 | Samsung Biologics Co Ltd | Healthcare | Biotechnology | 3.12% |
| MEDP | Medpace Holdings Inc | Healthcare | Diagnostics & Research | 3.05% |
| VRTX | Vertex Pharmaceuticals Inc | Healthcare | Biotechnology | 2.89% |
| AZN | AstraZeneca PLC | Healthcare | Drug Manufacturers - General | 2.77% |
| AZN_old | AstraZeneca PLC | Healthcare | Drug Manufacturers - General | 2.77% |
| CTVA | Corteva Inc | Basic Materials | Agricultural Inputs | 2.69% |
| REGN | Regeneron Pharmaceuticals Inc | Healthcare | Biotechnology | 2.64% |
| EXAS | EXACT Sciences Corporation | Healthcare | Diagnostics & Research | 2.61% |
| ALNY | Alnylam Pharmaceuticals Inc | Healthcare | Biotechnology | 2.58% |
| LLY | Eli Lilly and Company | Healthcare | Drug Manufacturers - General | 2.55% |
| IONS | Ionis Pharmaceuticals Inc | Healthcare | Biotechnology | 2.05% |